Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jayachandran R Panickar"'
Publikováno v:
International Journal of Mycobacteriology, Vol 7, Iss 3, Pp 257-260 (2018)
Background: Antimicrobial resistance (AMR) has rendered certain species of Mycobacterium difficult to treat clinically, particularly, the nontuberculous Mycobacterium, Mycobacterium abscessus. This bacterium is emerging in specific disease population
Externí odkaz:
https://doaj.org/article/28210000f9ad4f21a2d8c536b9964535
Publikováno v:
Food Quality and Safety. 3:93-97
Publikováno v:
International Journal of Mycobacteriology, Vol 7, Iss 3, Pp 257-260 (2018)
Background: Antimicrobial resistance (AMR) has rendered certain species of Mycobacterium difficult to treat clinically, particularly, the nontuberculous Mycobacterium, Mycobacterium abscessus. This bacterium is emerging in specific disease population
Autor:
Terence Stephenson, Jonathan Grigg, Alan R. Smyth, Jayachandran R. Panickar, Paul C. Lambert, Priti Kenia, Monica Lakhanpaul
Publikováno v:
New England Journal of Medicine. 360:329-338
Attacks of wheezing induced by upper respiratory viral infections are common in preschool children between the ages of 10 months and 6 years. A short course of oral prednisolone is widely used to treat preschool children with wheezing who present to
Autor:
Jayachandran R Panickar, Wren Hoskyns
Publikováno v:
European Respiratory Journal. 29:561-564
Treatment of latent tuberculosis (TB) infection with 3 months of rifampicin/isoniazid is a major part of preventive TB programmes. The effectiveness of treatment of latent TB infection can only be assessed by rates of subsequent breakdown and there a
Publikováno v:
Paediatric Respiratory Reviews. 7:293-298
The clinical diagnosis of asthma represents several putative wheeze phenotypes, each associated with a unique cluster of risk factors, underlying inflammation, and response to therapy. In school-age children, the 'classical' atopic asthma phenotype p
Publikováno v:
Pediatric pulmonology. 42(7)
In a previous study, we reported that intramuscular (IM) triamcinolone improves symptoms in children with difficult asthma. In 2005, we revised our difficult asthma protocol to include assessment of airway inflammation, both directly using sputum ind
Background: Childhood mortality has decreased markedly over the last three decades. A study was undertaken to determine trends in deaths from respiratory illness in children in England and Wales. Methods: Mortality data collected by the Office for Na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f731b5eb9a84a0883622effe8de4df48
https://europepmc.org/articles/PMC1747255/
https://europepmc.org/articles/PMC1747255/
Publikováno v:
Pediatric pulmonology. 39(5)
We treated a selected group of children attending a difficult asthma clinic with intramuscular triamcinolone acetonide. This study retrospectively reviews markers of asthma severity in those who received one or more monthly doses for three periods: 1
Publikováno v:
Pediatric Pulmonology; May2005, Vol. 39 Issue 5, p421-425, 5p